Your Messages Inbox
Your Article Summary
See Latest ArticlesAbbott Announces TCT 2009 Activities
Abbott, 09/17/09
Abbott announced the company's schedule of key news announcements and events during the Transcatheter Cardiovascular Therapeutics 2009 conference in San Francisco, September. Highlights include the presentation of new scientific data on the company's market–leading XIENCE V Everolimus Eluting Coronary Stent System. One–year results from the SPIRIT IV trial, which will be presented as a late–breaking clinical trial on Sept., will provide valuable information about the efficacy and safety of XIENCE V compared to Boston Scientific's TAXUS Paclitaxel–Eluting Coronary Stent System.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
Cell Therapeutics, 12/02/09
Cardinal Health helps hospitals improve safety, workflow, cost containment at 44 ASHP Midyear Clinical Meeting and Exhibition
Cardinal Health, 12/02/09
Genmab to present at 21st annual piper jaffray health care conference
Genmab, 12/02/09
Article Search
Sponsor